We are live on
!
Find out more
FI
Fosun International Portfolio holdings
AUM
$399M
1-Year Est. Return
16.11%
This Fund
S&P 500
This Quarter
Est. Return
+12.61%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.57B
AUM Growth
-$99.9M
(-6%)
Cap. Flow
-$270M
Cap. Flow
% of AUM
-17.18%
Top 10 Holdings %
Top 10 Hldgs %
52.85%
Holding
344
New
45
Increased
88
Reduced
69
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BZUN
Baozun
BZUN
|
+$17.1M |
| 2 |
MOMO
Hello Group
MOMO
|
+$5.31M |
| 3 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
+$4.25M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$4.13M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$3.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KANG
iKang Healthcare Group, Inc.
KANG
|
+$94.3M |
| 2 |
Vipshop
VIPS
|
+$47.3M |
| 3 |
DigitalBridge
DBRG
|
+$39.3M |
| 4 |
Brookdale Senior Living
BKD
|
+$37.8M |
| 5 |
Criteo S.A. Ordinary Shares
CRTO
|
+$15.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.62% |
| 2 | Financials | 6.46% |
| 3 | Consumer Discretionary | 4.13% |
| 4 | Industrials | 2.9% |
| 5 | Communication Services | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
AngloGold Ashanti
AU
$38.2B
| $387K | 0.02% |
30,000
-20,000
| -40% | -$269K |
|
227
Honeywell
HON
$76.3B
| $384K | 0.02% |
2,572
| – | – |
|
228
Axalta
AXTA
$7.59B
| $377K | 0.02% |
+15,000
| New | +$386K |
|
|
ACER
229
DELISTED
Acer Therapeutics Inc
ACER
| $373K | 0.02% |
15,700
| – | – |
|
230
Gold Fields
GFI
$28.8B
| $372K | 0.02% |
100,000
| – | – |
|
231
Ligand Pharmaceuticals
LGND
$5.89B
| $371K | 0.02% |
4,809
| – | – |
|
232
Verizon
VZ
$191B
| $350K | 0.02% |
+5,925
| New | +$336K |
|
233
Boston Beer
SAM
$1.9B
| $349K | 0.02% |
1,200
| – | – |
|
|
GNCA
234
DELISTED
Genocea Biosciences, Inc.
GNCA
| $345K | 0.02% |
71,379
+20,919
| +41% | +$103K |
|
|
MBAI
235
Check-Cap
MBAI
$8.27M
| $344K | 0.02% |
6,378
| – | – |
|
236
Intel
INTC
$483B
| $343K | 0.02% |
6,450
+2,050
| +47% | +$104K |
|
237
Kinross Gold
KGC
$27B
| $343K | 0.02% |
100,000
-50,000
| -33% | -$167K |
|
238
3M
MMM
$90.8B
| $334K | 0.02% |
1,914
-11,960
| -86% | -$2.01M |
|
239
TotalEnergies
TTE
$194B
| $330K | 0.02% |
6,000
| – | – |
|
|
FSTX
240
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $328K | 0.02% |
7,775
| – | – |
|
|
BLRX
241
BioLineRX
BLRX
$11.9M
| $313K | 0.02% |
1,217
-1,045
| -46% | -$304K |
|
242
Applied Materials
AMAT
$416B
| $308K | 0.02% |
8,000
| – | – |
|
243
Coeur Mining
CDE
$15.4B
| $307K | 0.02% |
+72,500
| New | +$350K |
|
|
JOYY
244
JOYY Inc
JOYY
$3.7B
| $307K | 0.02% |
3,649
-56,151
| -94% | -$4.08M |
|
245
Qorvo
QRVO
$7.87B
| $306K | 0.02% |
4,361
| – | – |
|
|
SYBX
246
DELISTED
Synlogic
SYBX
| $299K | 0.02% |
2,563
| – | – |
|
247
Boston Scientific
BSX
$66.9B
| $293K | 0.02% |
7,715
| – | – |
|
248
Intercontinental Exchange
ICE
$87.2B
| $289K | 0.02% |
+3,865
| New | +$290K |
|
|
CTIC
249
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $288K | 0.02% |
300,428
| – | – |
|
250
Charter Communications
CHTR
$16.8B
| $283K | 0.02% |
802
| – | – |
|
Similar funds
NC
T2I
BA
IAA
THL
MHC
BWM
KHCM
Fosun International's Q1 2019 Portfolio in Review
As of Q1 2019, Fosun International held 344 positions worth $1.57B, down 6% from $1.67B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Fosun International withdrew a net $270M in Q1 2019, closing 37 positions and reducing 69 holdings. Its most notable exit was iKang Healthcare Group, Inc., an estimated $94.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Fosun International opened a new position in Baozun worth $20.3M.
- Fosun International's largest Q1 2019 buy was Baozun: 488,992 shares worth $20.3M.
- Fosun International added most to Neurocrine Biosciences in Q1 2019, an estimated $3.26M increase.
- Fosun International's biggest Q1 2019 reduction was Vipshop, cutting an estimated $47.3M.
- Fosun International fully exited iKang Healthcare Group, Inc. in Q1 2019, selling an estimated $94.3M.
- Fosun International's ten largest holdings make up 53% of its $1.57B portfolio in Q1 2019.
- Fosun International opened 45 new positions and closed 37 in Q1 2019.
- Fosun International's portfolio value fell 6% quarter-over-quarter to $1.57B.
Based on Fosun International's 13F filing for Q1 2019, filed 10 May 2019.